All 252 IBB (ISHARES BIOTECHNOLOGY ETF) Holdings
There are 252 IBB holdings. Top 10 companies weight: 44.73%.
Total Market Cap: $1.60T
Rank | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Average | (252 stocks) | +19.98% | 23.69 | 17.29 | 0.53 | +25.34% | +9.82% | 0.81 | ||||||||||
1 | VRTX | Vertex Pharmaceuticals Inc | 8.10% | $482 | $121B | Biotechnology | Healthcare | +9.89% | 27.99 | 25.45 | 1.72 | N/A | N/A | 72 | +15.03% | $554 | +19.72% | 0.49 |
2 | AMGN | Amgen Inc | 7.81% | $366.24 | $193B | Drug Manufacturers - General | Healthcare | +3.49% | 24.75 | 16.47 | 0.79 | N/A | N/A | 60 | -2.63% | $357 | +11.87% | 0.46 |
3 | GILD | Gilead Sciences Inc | 6.82% | $130.28 | $164B | Drug Manufacturers - General | Healthcare | +98.59% | 17.75 | 15.22 | 0.32 | N/A | N/A | 74 | +21.51% | $158 | +17.88% | 0.35 |
4 | REGN | Regeneron Pharmaceuticals Inc | 4.92% | $675.19 | $69B | Biotechnology | Healthcare | +20.31% | 15.86 | 15.08 | 88.04 | N/A | N/A | 72 | +21.33% | $819 | +3.01% | 0.60 |
5 | ARGX | Argenx Se Adr | 3.68% | $874.74 | $57B | Biotechnology | Healthcare | N/A | 24.30 | 32.36 | 0.21 | N/A | N/A | 79 | +20.62% | $1.06K | +22.54% | 0.47 |
6 | ALNY | Alnylam Pharmaceuticals Inc | 3.13% | $271.37 | $37B | Biotechnology | Healthcare | N/A | 117.96 | 30.49 | 0.52 | N/A | N/A | 74 | +60.24% | $435 | +8.34% | 0.81 |
7 | NTRA | Natera Inc | 2.94% | $267.18 | $40B | Diagnostics & Research | Healthcare | -11.74% | N/A | N/A | N/A | N/A | N/A | 77 | +5.60% | $282 | +17.99% | 1.29 |
8 | RVMD | Revolution Medicines Inc Ordinary Shares | 2.78% | $183.29 | $37B | Biotechnology | Healthcare | +30.12% | N/A | N/A | N/A | N/A | N/A | 78 | +9.41% | $201 | +44.92% | 1.09 |
9 | BIIB | Biogen Inc | 2.39% | $203.16 | $29B | Drug Manufacturers - General | Healthcare | -15.32% | 17.41 | 14.75 | 0.64 | N/A | N/A | 65 | +11.39% | $226 | -9.04% | 0.51 |
10 | ILMN | Illumina Inc | 2.16% | $192.53 | $29B | Diagnostics & Research | Healthcare | -6.80% | 44.12 | 35.59 | 3.34 | N/A | N/A | 60 | -11.98% | $169 | -16.46% | 1.00 |
11 | MRNA | Moderna Inc | 2.05% | $59.66 | $27B | Biotechnology | Healthcare | N/A | N/A | 23.04 | N/A | N/A | N/A | 46 | -18.84% | $48 | -28.69% | 1.37 |
12 | ONC | Beone Medicines Ltd Adr | 1.81% | $318.69 | $36B | Biotechnology | Healthcare | N/A | 69.54 | 47.39 | N/A | N/A | N/A | 81 | +30.17% | $415 | -0.19% | 0.54 |
13 | INSM | Insmed Inc | 1.79% | $108.62 | $24B | Biotechnology | Healthcare | +12.24% | N/A | 16.37 | 1.09 | N/A | N/A | 80 | +80.80% | $196 | +34.13% | 0.77 |
14 | INCY | Incyte Corp | 1.76% | $117.39 | $23B | Biotechnology | Healthcare | +27.16% | 15.82 | 15.06 | N/A | N/A | N/A | 61 | -3.04% | $114 | +8.35% | 0.57 |
15 | UTHR | United Therapeutics Corp | 1.75% | $535.83 | $22B | Drug Manufacturers - Specialty & Generic | Healthcare | +26.56% | 17.96 | 19.23 | 1.91 | N/A | N/A | 75 | +23.82% | $663 | +23.60% | 0.41 |
16 | ROIV | Roivant Sciences Ltd Ordinary Shares | 1.41% | $34.96 | $25B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 76 | +12.47% | $39 | 0.00% | 0.90 |
17 | ASND | Ascendis Pharma As | 1.29% | $255.20 | $17B | Biotechnology | Healthcare | N/A | 30.09 | 15.82 | N/A | N/A | N/A | 80 | +18.16% | $302 | +16.81% | 0.44 |
18 | NBIX | Neurocrine Biosciences Inc | 1.29% | $179.05 | $17B | Drug Manufacturers - Specialty & Generic | Healthcare | +9.25% | 25.72 | 24.10 | 0.21 | N/A | N/A | 75 | +11.83% | $200 | +12.78% | 0.79 |
19 | GMAB | Genmab As Adr | 1.13% | $28.37 | $19B | Biotechnology | Healthcare | -30.81% | 140.29 | 16.95 | 1.91 | N/A | N/A | 70 | +30.16% | $37 | -8.56% | 0.59 |
20 | EXEL | Exelixis Inc | 1.03% | $56.12 | $14B | Biotechnology | Healthcare | +72.24% | 17.54 | 17.57 | 0.45 | N/A | N/A | 59 | -9.25% | $51 | +27.07% | 0.52 |
21 | IONS | Ionis Pharmaceuticals Inc | 1.00% | $53.39 | $9.08B | Biotechnology | Healthcare | -21.44% | N/A | 90.91 | N/A | N/A | N/A | 79 | +74.10% | $93 | +7.33% | 0.65 |
22 | MEDP | Medpace Holdings Inc | 0.98% | $531.67 | $15B | Diagnostics & Research | Healthcare | +29.42% | 32.55 | 31.35 | 1.67 | N/A | N/A | 57 | -11.16% | $472 | +24.17% | 1.00 |
23 | BBIO | Bridgebio Pharma Inc | 0.98% | $82.45 | $16B | Biotechnology | Healthcare | -3.14% | N/A | N/A | N/A | N/A | N/A | 79 | +27.67% | $105 | +5.99% | 1.03 |
24 | MDGL | Madrigal Pharmaceuticals Inc | 0.87% | $546.79 | $13B | Biotechnology | Healthcare | +23.26% | N/A | 666.67 | N/A | N/A | N/A | 76 | +24.15% | $679 | +43.16% | 0.76 |
25 | BMRN | Biomarin Pharmaceutical Inc | 0.86% | $59.21 | $11B | Biotechnology | Healthcare | -20.33% | 42.21 | 11.96 | 0.73 | N/A | N/A | 75 | +48.56% | $88 | -5.47% | 0.64 |
26 | TECH | Bio-techne Corp | 0.86% | $71.63 | $11B | Biotechnology | Healthcare | -10.07% | 101.96 | 34.48 | 0.96 | N/A | N/A | 58 | -2.28% | $70 | -8.97% | 1.12 |
27 | CRL | N/A | 0.85% | $219.35 | $11B | Diagnostics & Research | Healthcare | N/A | N/A | 20.16 | N/A | N/A | N/A | 75 | +5.28% | $231 | -11.02% | 1.38 |
28 | ARWR | Arrowhead Pharmaceuticals Inc | 0.83% | $74.52 | $10B | Biotechnology | Healthcare | +15.23% | N/A | 111.11 | N/A | N/A | N/A | 78 | +28.82% | $96 | +1.87% | 1.64 |
29 | AXSM | Axsome Therapeutics Inc | 0.81% | $236.95 | $12B | Biotechnology | Healthcare | +6.89% | N/A | 333.33 | N/A | N/A | N/A | 77 | +18.33% | $280 | +33.50% | 0.67 |
30 | CYTK | Cytokinetics Inc | 0.79% | $81.11 | $10B | Biotechnology | Healthcare | +27.73% | N/A | 117.65 | N/A | N/A | N/A | 80 | +32.91% | $108 | +21.93% | 0.77 |
31 | KRYS | Krystal Biotech Inc | 0.75% | $339.06 | $10B | Biotechnology | Healthcare | N/A | 45.34 | 44.84 | 0.57 | N/A | N/A | 72 | +6.67% | $362 | +40.35% | 0.92 |
32 | HALO | Halozyme Therapeutics Inc | 0.71% | $78.60 | $8.99B | Biotechnology | Healthcare | +20.06% | 25.62 | 10.78 | N/A | N/A | N/A | 67 | +6.74% | $84 | +13.10% | 0.62 |
33 | BNTX | Biontech Se Adr | 0.67% | $92.33 | $23B | Biotechnology | Healthcare | N/A | N/A | 7.04 | N/A | N/A | N/A | 70 | +32.16% | $122 | -19.59% | 0.94 |
34 | ABVX | Abivax Sa Adr | 0.67% | $134.09 | $11B | Biotechnology | Healthcare | +25.56% | N/A | N/A | N/A | N/A | N/A | 84 | +20.07% | $161 | 0.00% | 1.85 |
35 | ALKS | Alkermes Plc | 0.66% | $52.85 | $8.65B | Drug Manufacturers - Specialty & Generic | Healthcare | N/A | 56.04 | 136.99 | 1.96 | N/A | N/A | N/A | N/A | N/A | +16.96% | N/A |
36 | PRAX | N/A | 0.65% | $317.87 | $8.87B | Biotechnology | Healthcare | -18.18% | N/A | N/A | N/A | N/A | N/A | 75 | +91.92% | $610 | +4.14% | 0.93 |
37 | KYMR | Kymera Therapeutics Inc Ordinary Shares | 0.63% | $113.37 | $9.38B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 79 | +10.38% | $125 | +14.59% | 1.53 |
38 | PCVX | Vaxcyte Inc Ordinary Shares | 0.62% | $58.04 | $8.19B | Biotechnology | Healthcare | +33.90% | N/A | N/A | N/A | N/A | N/A | 75 | +87.80% | $109 | +20.85% | 0.73 |
39 | PTGX | Protagonist Therapeutics Inc | 0.60% | $138.31 | $8.70B | Biotechnology | Healthcare | +1.43% | N/A | 28.41 | N/A | N/A | N/A | 78 | -9.51% | $125 | +24.19% | 0.22 |
40 | APGE | Apogee Therapeutics Inc | 0.59% | $134.20 | $10B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 0.00% | N/A |
41 | RGEN | Repligen Corp | 0.58% | $136.99 | $8.35B | Medical Instruments & Supplies | Healthcare | +9.09% | 162.20 | 74.63 | 0.62 | N/A | N/A | 75 | +29.97% | $178 | -7.84% | 1.31 |
42 | RYTM | Rhythm Pharmaceuticals Inc | 0.57% | $106.60 | $7.51B | Biotechnology | Healthcare | +17.00% | N/A | N/A | N/A | N/A | N/A | 79 | +31.08% | $140 | +40.62% | 0.88 |
43 | SYRE | Spyre Therapeutics Inc | 0.54% | $102.70 | $8.05B | Biotechnology | Healthcare | -2.15% | N/A | N/A | N/A | N/A | N/A | 75 | +1.20% | $104 | -9.05% | 1.75 |
44 | BRKR | Bruker Corp | 0.53% | $60.43 | $8.93B | Medical Devices | Healthcare | N/A | N/A | 15.22 | 1.52 | N/A | N/A | 67 | -1.13% | $60 | -5.48% | 1.24 |
45 | PTCT | Ptc Therapeutics Inc | 0.51% | $78.50 | $6.53B | Biotechnology | Healthcare | -16.59% | N/A | 56.50 | 0.81 | N/A | N/A | 75 | +22.20% | $96 | +13.28% | 0.99 |
46 | TEM | Tempus Ai Inc Class A Common Stock | 0.51% | $48.98 | $10B | Health Information Services | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 65 | +35.91% | $67 | 0.00% | 2.68 |
47 | NUVL | Nuvalent Inc Class A | 0.50% | $123.96 | $9.75B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 50 | +0.03% | $124 | 0.00% | 0.97 |
48 | TWST | Twist Bioscience Corp | 0.48% | $95.86 | $5.76B | Diagnostics & Research | Healthcare | -10.29% | N/A | N/A | N/A | N/A | N/A | 77 | -7.68% | $89 | -4.63% | 2.04 |
49 | MIRM | Mirum Pharmaceuticals Inc | 0.47% | $117.05 | $7.37B | Biotechnology | Healthcare | -34.51% | N/A | 2000.00 | N/A | N/A | N/A | 82 | +25.16% | $147 | +49.35% | 0.84 |
50 | COGT | Cogent Biosciences Inc | 0.44% | $39.64 | $6.71B | Biotechnology | Healthcare | -15.32% | N/A | N/A | N/A | N/A | N/A | 75 | +36.86% | $54 | +42.82% | 1.71 |
IBB (ISHARES BIOTECHNOLOGY ETF) Sector Allocation
HEALTHCARE
94.30%INFORMATION TECHNOLOGY
0.00%COMMUNICATION SERVICES
0.00%CONSUMER DISCRETIONARY
0.00%CONSUMER STAPLES
0.00%INDUSTRIALS
0.00%MATERIALS
0.00%UTILITIES
0.00%ENERGY
0.00%FINANCIALS
0.00%REAL ESTATE
0.00%